Skip to content

Drug interactions

Fedratinib + Linagliptin

Severity: Minor

Fedratinib and Linagliptin: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Fedratinib is a moderate CYP3A4 inhibitor and may increase linagliptin exposure. Because linagliptin is mostly excreted unchanged, the increase is unlikely to be clinically important.

What this interaction means in plain words

Fedratinib and Linagliptin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Fedratinib belongs to Oncology; Linagliptin belongs to Endocrine.

Evidence level: Low

Why it happens

Inhibition of CYP3A4 by fedratinib reduces linagliptin metabolism.

What to do

No dose change needed; monitor for hypoglycemia if combined with other glucose-lowering drugs.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Fedratinib and Linagliptin, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Fedratinib with Linagliptin?

MediHelp rates the interaction as minor. Fedratinib and Linagliptin have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Fedratinib is a moderate CYP3A4 inhibitor and may increase linagliptin exposure. Because linagliptin is mostly excreted unchanged, the increase is unlikely to be clinically important.

How serious is the interaction between Fedratinib and Linagliptin?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No dose change needed; monitor for hypoglycemia if combined with other glucose-lowering drugs.

What other medicines interact with Linagliptin?

MediHelp also lists interactions of Linagliptin with, for example, Alogliptin-pioglitazone, Amlodipine-benazepril, Amobarbital. The full list is on the Linagliptin page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in